Submission Details
| 510(k) Number | K231539 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 30, 2023 |
| Decision Date | October 21, 2023 |
| Days to Decision | 144 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K231539 is an FDA 510(k) clearance for the pRESET LITE Thrombectomy Device, a Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (Class II — Special Controls, product code POL), submitted by Phenox Limited (Galway, IE). The FDA issued a Cleared decision on October 21, 2023, 144 days after receiving the submission on May 30, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5600.
| 510(k) Number | K231539 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 30, 2023 |
| Decision Date | October 21, 2023 |
| Days to Decision | 144 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | POL — Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5600 |
| Definition | A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature. |